Oncodesign Services, a leading CRO in drug discovery and preclinical services
Innovative services & quality deliverables to accelerate your research program
Oncodesign Services is a contract research organization (CRO) specialized in drug discovery whose mission is to contribute to the discovery of innovative therapies against cancers and serious diseases with high medical needs.
Find out more about what we can offer you depending on the stage of development of your drug discovery project!
Drug candidate
Our solution:
Solo
- POC Oncology
- POC Inflammation
- COVID-19
- Pharmaco-Imaging
- DMPK – Bioanalysis
- Microbiome
Our Therapeutic Areas
Oncology
Since the inception of the company, we have been pioneering in translational pharmacology to study and treat cancer...
Inflammation
We have a big collection of preclinical inflammatory and autoimmune models, covering diseases of the skin, gut, lungs, kidneys, liver and more...
Infectious diseases
We have BSL2 and BSL3 facilities and local partnerships allowing infectious diseases models to be run...
22/05/2023
Oncodesign Services and Veritas In Silico Inc. announced that they have entered into a Memorandum of Understanding to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting messenger RNA.
17/05/2023
![[EN] Preclinical Models for the Identification of Chemotherapy Predictive Signatures in Pancreatic Cancer](https://www.oncodesign-services.com/wp-content/webp-express/webp-images/uploads/2023/05/Banniere-Go-to-300x173.png.webp)
Join the featured speakers to learn how they utilized preclinical models such as primary cell cultures, patient-derived xenografts, and patient-derived organoids to develop unbiased predictive RNA-based signatures.
